Page 3 - Use Authorisation News Today

Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.

Commending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against COVID-19, the Indian pharma giant has said its discussions with Moderna on the COVID-19 booster vaccine are nearing finalisation and for that, they are seeking the "partnership and support of the government to make this programme successful".

Cipla has requested the government for indemnification & exemptions from price capping, bridging trials, and basic customs duty to bring Moderna's COVID vaccine

Read more about Cipla says close to committing $1 billion to Moderna for booster vaccine on Business Standard. The company has further requested for the governments assurance that no price capping would apply for imported vaccines to be provided through private hospitals

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19 -- The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19 -- Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease PLEASANTO...

By Syndicated Content May 18, 2021 | 12:16 AM ZURICH (Reuters) – Roche’s cobas SARS-CoV-2 Test has received U.S. authorisation for testing individuals without symptoms or reasons to suspect a COVID-19 infection, the Swiss drugmaker said on Tuesday. “The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19,” Roche said...

• Any COVID-19 vaccine not through government channels should be considered as counterfeit, say experts • Guild of Medical Directors, security experts call for robust surveillance to check fake COVID-19 vaccines • Want NAFDAC to test all batches of COVID-19 vaccines Three days after Nigeria began vaccination for coronavirus, there are concerns that fake and illegal COVID-19 vaccines may soon flood the Nigerian market if the Federal Government did not tackle the situation urgently. ...

The Presidential Task Force (PTF) on COVID-19 says it is expecting three types of vaccines for Nigerians. The federal government has approved Nnamdi

Business Scoop provides news and views on Business and Markets from New Zealand

Investegate announcements from F. Hoffmann-La Roche Ltd, EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19